Osteoporosis in patients with chronic kidney diseases: a systemic review

CY Hsu, LR Chen, KH Chen - International journal of molecular sciences, 2020 - mdpi.com
Chronic kidney disease (CKD) is associated with the development of mineral bone disorder
(MBD), osteoporosis, and fragility fractures. Among CKD patients, adynamic bone disease or …

Mineral bone disorders in kidney disease patients: the ever-current topic

L Hu, A Napoletano, M Provenzano, C Garofalo… - International Journal of …, 2022 - mdpi.com
Chronic kidney disease (CKD) is a complex and multifactorial disease, and one of the most
prevalent worldwide. Chronic kidney disease–mineral bone disorders (CKD–MBD) with …

[HTML][HTML] Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

T Isakova, P Wahl, GS Vargas, OM Gutiérrez… - Kidney international, 2011 - Elsevier
Fibroblast growth factor 23 (FGF23) regulates phosphorus metabolism and is a strong
predictor of mortality in dialysis patients. FGF23 is thought to be an early biomarker of …

Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism

MC Hu, K Shiizaki, M Kuro-o… - Annual review of …, 2013 - annualreviews.org
The metabolically active and perpetually remodeling calcium phosphate–based
endoskeleton in terrestrial vertebrates sets the demands on whole-organism calcium and …

Regulation and function of the FGF23/klotho endocrine pathways

A Martin, V David, LD Quarles - Physiological reviews, 2012 - journals.physiology.org
Calcium (Ca2+) and phosphate (PO43−) homeostasis are coordinated by systemic and local
factors that regulate intestinal absorption, influx and efflux from bone, and kidney excretion …

Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options

J Cunningham, F Locatelli… - Clinical Journal of the …, 2011 - journals.lww.com
Secondary hyperparathyroidism (SHPT) is a challenge frequently encountered in the
management of patients with chronic kidney disease (CKD). Downregulation of the …

Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23

K Lim, TS Lu, G Molostvov, C Lee, FT Lam, D Zehnder… - Circulation, 2012 - Am Heart Assoc
Background—Klotho is known to function as a cofactor for the phosphatonin, fibroblast
growth factor (FGF)-23 at the kidney. FGF-23 levels rise in chronic kidney disease (CKD) …

Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease

SM Moe, MP Zidehsarai, MA Chambers… - Clinical Journal of the …, 2011 - journals.lww.com
Results The results indicated that 1 week of a vegetarian diet led to lower serum phosphorus
levels and decreased FGF23 levels. The inpatient stay demonstrated similar diurnal …

[HTML][HTML] Update on fibroblast growth factor 23 in chronic kidney disease

M Wolf - Kidney international, 2012 - Elsevier
Chronic kidney disease (CKD) is a public health epidemic that affects millions of people
worldwide. Presence of CKD predisposes individuals to high risks of end-stage renal …

The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB

JA Moreno, MC Izquierdo… - Journal of the …, 2011 - journals.lww.com
Proinflammatory cytokines contribute to renal injury, but the downstream effectors within
kidney cells are not well understood. One candidate effector is Klotho, a protein expressed …